Transgender populations in the United States have been impacted by the HIV/AIDS epidemic. This systematic review estimates the prevalence of HIV infection and risk behaviors of transgender persons. Comprehensive searches of the US-based HIV behavioral prevention literature identified 29 studies focusing on male-to-female (MTF) transgender women; five of these studies also reported data on female-to-male (FTM) transgender men. Using meta-analytic approaches, prevalence rates were estimated by synthesizing weighted means. Meta-analytic findings indicated that 27.7% (95% confidence interval [CI], 24.8–30.6%) of MTFs tested positive for HIV infection (four studies), while 11.8% (95% CI, 10.5–13.2%) of MTFs self-reported being HIVseropositive (18 studies). Higher HIV infection rates were
found among African-American MTFs regardless of assessment method (56.3% test result; 30.8% self-report). Large percentages of MTFs (range, 27–48%) reported engaging in risky behaviors (e.g., unprotected receptive anal intercourse, multiple casual partners, sex work). Prevalence rates of HIV and risk behaviors were low among FTMs. Contextual factors potentially related to increased HIV risk include mental health concerns, physical abuse, social isolation, economic marginalization, and unmet transgender-specific healthcare needs. Additional research is needed to explain the causes of HIV risk
behavior of transgender persons. These findings should be considered when developing and adapting prevention interventions for transgender populations.
Please contact Vel S. McKleroy at vem4@cdc.gov for a copy of this article.
Comments
HIV Prevalence and Risk Behaviors of Transgender Persons
I just uploaded the abstract of a manuscript that has recently been e-published on AIDS & Behavior's "Online First" site. "Estimating HIV Prevalence and Risk Behaviors of Transgender Persons in the United States: A Systematic Review" explores HIV risk and the contextual factors that may increase the likelihood that transgender persons will engage in risky behaviors.